NetScientific plc

Equities

NSCI

GB00BN4R5Q82

Investment Management & Fund Operators

Market Closed - London S.E. Other stock markets 11:35:17 2024-05-13 am EDT			5-day change	1st Jan Change
64.5 ^GBX	+1.57%		+3.20%	+7.50%

May. 13	EARNINGS AND TRADING: itim loss narrows; Vela trims EnSilica stake	AN
May. 13	Netscientific Unit Agrees to Manage Martlet Capital’s GBP23 Million Portfolio	MT

SageTech Medical Equipment announced that it has received £2.9 million in funding from EMV Capital Ltd, NetScientific plc and other investors

May 12, 2021

On May 13, 2021, SageTech Medical Equipment closed the transaction. The company amended the terms of the transaction. The company received £1,620,000 in funding in it's second tranche. The company received a total of £2,900,000 in funding, in the transaction. The transaction included participation from EMV Capital Ltd for £1,600,000 and from new investor NetScientific plc (AIM:NSCI) for £200,000.

Latest news about NetScientific plc

EARNINGS AND TRADING: itim loss narrows; Vela trims EnSilica stake	May. 13	AN
Netscientific Unit Agrees to Manage Martlet Capital’s GBP23 Million Portfolio	May. 13	MT
NetScientific says PDS Biotech's Versamune meets endpoints	May. 10	AN
Netscientific's ProAxsis Secures Investment for Product Development	Apr. 15	MT
NetScientific investee secures funding to develop product range	Apr. 15	AN
Empire Metals targets key milestones in Australia	Mar. 27	AN
NetScientific "significantly" advances strategic goals	Mar. 13	AN
Esken's Southend Airport faces further allegations	Jan. 23	AN
Netscientific's Glycotest Receives $1 Million Investment from Fosun	Jan. 23	MT
Glycotest, Inc. announced that it has received $1 million in funding from EMV Capital Ltd, NetScientific plc, Shanghai Fosun Pharmaceutical Co., Ltd.	Jan. 22	CI
NetScientific's DeepTech Recycling Closes GBP1 Million Fundraising	Dec. 01	MT
NetScientific investee DeepTech Recycling bags GBP1 million	Dec. 01	AN
NetScientific's portfolio company updates on cancer trial	Nov. 09	AN
Pds Biotech Announces Updated Survival Data from Nci-Led Phase 2 Clinical Trial of Pds0101-Based Triple Combination Therapy in Advanced Hpv16-Positive Cancer Patients	Nov. 09	CI
NetScientific's EMV Leads Investment Round in Portfolio Company Ventive	Nov. 06	MT
NetScientific investee claims promising results in biomarker study	23-10-23	AN
NetScientific portfolio company updates on cancer trial	23-10-03	AN
EARNINGS: Dar Global profit multiplies, Hemogenyx loss widens	23-09-28	AN
Earnings Flash (NSCI.L) NETSCIENTIFIC Posts H1 Revenue GBP770,000	23-09-28	MT
NetScientific plc Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-28	CI
NetScientific's Q-Bot completes GBP3.5 million investment programme	23-09-13	AN
NetScientific's PDS suffers wider loss as R&D costs mount	23-08-14	AN
Pendragon quarterly trading momentum maintained	23-06-30	AN
DName-iT NV announced that it has received Â£0.5 million in funding from NetScientific plc, EMV Capital Ltd, KBC Group NV, BNP Paribas Fortis SA and other investors	23-06-29	CI
TinyBuild bemoans disappointing interim performance	23-06-29	AN

Chart NetScientific plc

Duration

Period

More charts

Company Profile

NetScientific plc is a United Kingdom-based deep tech and life sciences venture capital (VC) investment group with an international portfolio of innovative companies. The Company identifies, invests in, and builds high growth companies in the United Kingdom and internationally. It employs a capital-light investment approach, making use of its balance sheet and syndicating investments through its wholly owned VC subsidiary, EMV Capital Limited. The Company secures a mixture of direct equity stakes and carried interest stakes in its portfolio of companies, creating a structure that can support a large portfolio. Its portfolio consists of a combination of direct investments and capital under advisory (CUA). The Company has about 24 portfolio companies with a focus on life sciences, technology, and sustainability. The Company's subsidiaries include EMV Capital Limited, Glycotest, Inc., and ProAxsis Limited, among others.

Sector

Investment Management & Fund Operators

Calendar

2024-09-25 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Venture Capital

	1st Jan change	Capi.
NETSCIENTIFIC PLC	+7.50%	19.39M
HERCULES CAPITAL, INC.	+14.52%	3.06B
UMBRA COMPANIES INC.	+31.41%	2.06B
HBM HEALTHCARE INVESTMENTS AG	+9.31%	1.52B
OCTOPUS TITAN VCT PLC	-11.54%	1.19B
MOLTEN VENTURES PLC	+10.41%	723M
CION INVESTMENT CORPORATION	+8.49%	661M
VERUSA HOLDING	+26.90%	543M
OCTOPUS APOLLO VCT PLC	-4.17%	499M
WOORI TECHNOLOGY INVESTMENT CO., LTD	+24.84%	458M

Venture Capital